1j2f › Citations

X-ray crystal structure of IRF-3 and its functional implications.

Takahasi K, Suzuki NN, Horiuchi M, Mori M, Suhara W, Okabe Y, Fukuhara Y, Terasawa H, Akira S, Fujita T, Inagaki F
Nat Struct Biol 10 922-7 (2003)
Cited: 108 times
EuropePMC logo PMID: 14555995

Abstract

Transcription factor IRF-3 is post-translationally activated by Toll-like receptor (TLR) signaling and has critical roles in the regulation of innate immunity. Here we present the X-ray crystal structure of the C-terminal regulatory domain of IRF-3(175-427) (IRF-3 175C) at a resolution of 2.3 A. IRF-3 175C is structurally similar to the Mad homology domain 2 of the Smad family. Structural and functional analyses reveal phosphorylation-induced IRF-3 dimerization, which generates an extensive acidic pocket responsible for binding with p300/CBP. Although TLR and Smad signaling are evolutionarily independent, our results suggest that IRF-3 originates from Smad and acquires its function downstream of TLR.

Articles - 1j2f mentioned but not cited (7)

  1. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species. Moustaqil M, Ollivier E, Chiu HP, Van Tol S, Rudolffi-Soto P, Stevens C, Bhumkar A, Hunter DJB, Freiberg AN, Jacques D, Lee B, Sierecki E, Gambin Y. Emerg Microbes Infect 10 178-195 (2021)
  2. Association of a functional IRF7 variant with systemic lupus erythematosus. Fu Q, Zhao J, Qian X, Wong JL, Kaufman KM, Yu CY, Hwee Siew Howe, Tan Tock Seng Hospital Lupus Study Group, Mok MY, Harley JB, Guthridge JM, Song YW, Cho SK, Bae SC, Grossman JM, Hahn BH, Arnett FC, Shen N, Tsao BP. Arthritis Rheum 63 749-754 (2011)
  3. Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45. Sathish N, Zhu FX, Golub EE, Liang Q, Yuan Y. J Biol Chem 286 746-756 (2011)
  4. Identification of a novel in vivo virus-targeted phosphorylation site in interferon regulatory factor-3 (IRF3). Bergstroem B, Johnsen IB, Nguyen TT, Hagen L, Slupphaug G, Thommesen L, Anthonsen MW. J Biol Chem 285 24904-24914 (2010)
  5. DROIDS 1.20: A GUI-Based Pipeline for GPU-Accelerated Comparative Protein Dynamics. Babbitt GA, Mortensen JS, Coppola EE, Adams LE, Liao JK. Biophys J 114 1009-1017 (2018)
  6. IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation. Popli S, Chakravarty S, Fan S, Glanz A, Aras S, Nagy LE, Sen GC, Chakravarti R, Chattopadhyay S. Proc Natl Acad Sci U S A 119 e2121385119 (2022)
  7. Divergent mutations of Delta and Omicron variants: key players behind differential viral attributes across the COVID-19 waves. Panja A, Roy J, Mazumder A, Choudhury SM. Virusdisease 1-14 (2023)


Reviews citing this publication (26)

  1. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Honda K, Takaoka A, Taniguchi T. Immunity 25 349-360 (2006)
  2. The IRF family transcription factors in immunity and oncogenesis. Tamura T, Yanai H, Savitsky D, Taniguchi T. Annu Rev Immunol 26 535-584 (2008)
  3. IRF7: activation, regulation, modification and function. Ning S, Pagano JS, Barber GN. Genes Immun 12 399-414 (2011)
  4. Regulation of the type I IFN induction: a current view. Honda K, Yanai H, Takaoka A, Taniguchi T. Int Immunol 17 1367-1378 (2005)
  5. Structural determinants of Smad function in TGF-β signaling. Macias MJ, Martin-Malpartida P, Massagué J. Trends Biochem Sci 40 296-308 (2015)
  6. The IRF family, revisited. Paun A, Pitha PM. Biochimie 89 744-753 (2007)
  7. The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. Negishi H, Taniguchi T, Yanai H. Cold Spring Harb Perspect Biol 10 a028423 (2018)
  8. Roles of interferon-regulatory factors in T-helper-cell differentiation. Lohoff M, Mak TW. Nat Rev Immunol 5 125-135 (2005)
  9. Regulating IRFs in IFN Driven Disease. Jefferies CA. Front Immunol 10 325 (2019)
  10. The interferon regulatory factor family in host defense: mechanism of action. Ozato K, Tailor P, Kubota T. J Biol Chem 282 20065-20069 (2007)
  11. Interferon-regulatory factors determine macrophage phenotype polarization. Günthner R, Anders HJ. Mediators Inflamm 2013 731023 (2013)
  12. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network. Chinenov Y, Rogatsky I. Mol Cell Endocrinol 275 30-42 (2007)
  13. IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Biswas PS, Bhagat G, Pernis AB. Immunol Rev 233 79-96 (2010)
  14. Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease. Antonczyk A, Krist B, Sajek M, Michalska A, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HAR. Front Immunol 10 1176 (2019)
  15. Structural insights into interferon regulatory factor activation. Chen W, Royer WE. Cell Signal 22 883-887 (2010)
  16. Structural Basis of Intracellular TGF-β Signaling: Receptors and Smads. Chaikuad A, Bullock AN. Cold Spring Harb Perspect Biol 8 a022111 (2016)
  17. Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages. Solis M, Goubau D, Romieu-Mourez R, Genin P, Civas A, Hiscott J. Biochem Pharmacol 72 1469-1476 (2006)
  18. Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus. Glanz A, Chakravarty S, Varghese M, Kottapalli A, Fan S, Chakravarti R, Chattopadhyay S. Viruses 13 575 (2021)
  19. Specificity and Function of IRF Family Transcription Factors: Insights from Genomics. Mancino A, Natoli G. J Interferon Cytokine Res 36 462-469 (2016)
  20. Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based? Thompson CD, Matta B, Barnes BJ. Front Immunol 9 2622 (2018)
  21. The role of acetylation in TLR4-mediated innate immune responses. Hu X, Yu Y, Eugene Chin Y, Xia Q. Immunol Cell Biol 91 611-614 (2013)
  22. Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity. Rogatsky I, Chandrasekaran U, Manni M, Yi W, Pernis AB. Autoimmunity 47 242-255 (2014)
  23. A Synchronous IRF4-Dependent Gene Regulatory Network in B and Helper T Cells Orchestrating the Antibody Response. Cook SL, Franke MC, Sievert EP, Sciammas R. Trends Immunol 41 614-628 (2020)
  24. Poxviral Targeting of Interferon Regulatory Factor Activation. Lawler C, Brady G. Viruses 12 E1191 (2020)
  25. Viral recognition and the antiviral interferon response. Dalskov L, Gad HH, Hartmann R. EMBO J 42 e112907 (2023)
  26. Current progress on innate immune evasion mediated by Npro protein of pestiviruses. Wen S, Li X, Lv X, Liu K, Ren J, Zhai J, Song Y. Front Immunol 14 1136051 (2023)

Articles citing this publication (75)

  1. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. Nat Immunol 5 730-737 (2004)
  2. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV, Chen ZJ. Science 347 aaa2630 (2015)
  3. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. Brzózka K, Finke S, Conzelmann KK. J Virol 79 7673-7681 (2005)
  4. TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. Kimura T, Jain A, Choi SW, Mandell MA, Schroder K, Johansen T, Deretic V. J Cell Biol 210 973-989 (2015)
  5. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Chang TH, Liao CL, Lin YL. Microbes Infect 8 157-171 (2006)
  6. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Qin BY, Liu C, Lam SS, Srinath H, Delston R, Correia JJ, Derynck R, Lin K. Nat Struct Biol 10 913-921 (2003)
  7. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. Biswas PS, Gupta S, Chang E, Song L, Stirzaker RA, Liao JK, Bhagat G, Pernis AB. J Clin Invest 120 3280-3295 (2010)
  8. Acetylation-dependent signal transduction for type I interferon receptor. Tang X, Gao JS, Guan YJ, McLane KE, Yuan ZL, Ramratnam B, Chin YE. Cell 131 93-105 (2007)
  9. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. tenOever BR, Sharma S, Zou W, Sun Q, Grandvaux N, Julkunen I, Hemmi H, Yamamoto M, Akira S, Yeh WC, Lin R, Hiscott J. J Virol 78 10636-10649 (2004)
  10. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. Panne D, Maniatis T, Harrison SC. EMBO J 23 4384-4393 (2004)
  11. Crystal structure of IRF-3 in complex with CBP. Qin BY, Liu C, Srinath H, Lam SS, Correia JJ, Derynck R, Lin K. Structure 13 1269-1277 (2005)
  12. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Chen W, Lam SS, Srinath H, Jiang Z, Correia JJ, Schiffer CA, Fitzgerald KA, Lin K, Royer WE. Nat Struct Mol Biol 15 1213-1220 (2008)
  13. Innate and adaptive immune responses to herpes simplex virus. Chew T, Taylor KE, Mossman KL. Viruses 1 979-1002 (2009)
  14. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. Ikeda F, Hecker CM, Rozenknop A, Nordmeier RD, Rogov V, Hofmann K, Akira S, Dötsch V, Dikic I. EMBO J 26 3451-3462 (2007)
  15. Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity. Mathew R, Khor S, Hackett SR, Rabinowitz JD, Perlman DH, White E. Mol Cell 55 916-930 (2014)
  16. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. Wang H, Garcia CA, Rehani K, Cekic C, Alard P, Kinane DF, Mitchell T, Martin M. J Immunol 181 6797-6802 (2008)
  17. A preformed binding interface in the unbound ensemble of an intrinsically disordered protein: evidence from molecular simulations. Knott M, Best RB. PLoS Comput Biol 8 e1002605 (2012)
  18. Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer. Escalante CR, Nistal-Villán E, Shen L, García-Sastre A, Aggarwal AK. Mol Cell 26 703-716 (2007)
  19. Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. Clément JF, Bibeau-Poirier A, Gravel SP, Grandvaux N, Bonneil E, Thibault P, Meloche S, Servant MJ. J Virol 82 3984-3996 (2008)
  20. Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7. Génin P, Lin R, Hiscott J, Civas A. Mol Cell Biol 29 3435-3450 (2009)
  21. Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3. Chen W, Srinath H, Lam SS, Schiffer CA, Royer WE, Lin K. J Mol Biol 379 251-260 (2008)
  22. Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation. Meng F, Zhou R, Wu S, Zhang Q, Jin Q, Zhou Y, Plouffe SW, Liu S, Song H, Xia Z, Zhao B, Ye S, Feng XH, Guan KL, Zou J, Xu P. Genes Dev 30 1086-1100 (2016)
  23. Thogoto virus ML protein suppresses IRF3 function. Jennings S, Martínez-Sobrido L, García-Sastre A, Weber F, Kochs G. Virology 331 63-72 (2005)
  24. Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain. Arnold MM, Barro M, Patton JT. J Virol 87 9813-9821 (2013)
  25. Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling. Xu P, Bailey-Bucktrout S, Xi Y, Xu D, Du D, Zhang Q, Xiang W, Liu J, Melton A, Sheppard D, Chapman HA, Bluestone JA, Derynck R. Mol Cell 56 723-737 (2014)
  26. Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change. Takahasi K, Horiuchi M, Fujii K, Nakamura S, Noda NN, Yoneyama M, Fujita T, Inagaki F. Genes Cells 15 901-910 (2010)
  27. Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7. Caillaud A, Hovanessian AG, Levy DE, Marié IJ. J Biol Chem 280 17671-17677 (2005)
  28. Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function. Rengachari S, Groiss S, Devos JM, Caron E, Grandvaux N, Panne D. Proc Natl Acad Sci U S A 115 E601-E609 (2018)
  29. Inhibition of the IFN-beta response in hepatocellular carcinoma by alternative spliced isoform of IFN regulatory factor-3. Marozin S, Altomonte J, Stadler F, Thasler WE, Schmid RM, Ebert O. Mol Ther 16 1789-1797 (2008)
  30. Mechanisms of activation of interferon regulator factor 3: the role of C-terminal domain phosphorylation in IRF-3 dimerization and DNA binding. Dragan AI, Hargreaves VV, Makeyeva EN, Privalov PL. Nucleic Acids Res 35 3525-3534 (2007)
  31. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways. Sugiyama Y, Kakoi K, Kimura A, Takada I, Kashiwagi I, Wakabayashi Y, Morita R, Nomura M, Yoshimura A. Int Immunol 24 253-265 (2012)
  32. Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling. Nociari M, Ocheretina O, Murphy M, Falck-Pedersen E. J Virol 83 4081-4091 (2009)
  33. Inhibition of IRF5 hyperactivation protects from lupus onset and severity. Song S, De S, Nelson V, Chopra S, LaPan M, Kampta K, Sun S, He M, Thompson CD, Li D, Shih T, Tan N, Al-Abed Y, Capitle E, Aranow C, Mackay M, Clapp WL, Barnes BJ. J Clin Invest 130 6700-6717 (2020)
  34. IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of β-catenin. Tian M, Wang X, Sun J, Lin W, Chen L, Liu S, Wu X, Shi L, Xu P, Cai X, Wang X. Nat Commun 11 5762 (2020)
  35. The second messenger phosphatidylinositol-5-phosphate facilitates antiviral innate immune signaling. Kawasaki T, Takemura N, Standley DM, Akira S, Kawai T. Cell Host Microbe 14 148-158 (2013)
  36. Rubicon Modulates Antiviral Type I Interferon (IFN) Signaling by Targeting IFN Regulatory Factor 3 Dimerization. Kim JH, Kim TH, Lee HC, Nikapitiya C, Uddin MB, Park ME, Pathinayake P, Lee ES, Chathuranga K, Herath TUB, Chathuranga WAG, Lee JS. J Virol 91 e00248-17 (2017)
  37. Characterization of distinct molecular interactions responsible for IRF3 and IRF7 phosphorylation and subsequent dimerization. Dalskov L, Narita R, Andersen LL, Jensen N, Assil S, Kristensen KH, Mikkelsen JG, Fujita T, Mogensen TH, Paludan SR, Hartmann R. Nucleic Acids Res 48 11421-11433 (2020)
  38. IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosis. Nakhaei P, Sun Q, Solis M, Mesplede T, Bonneil E, Paz S, Lin R, Hiscott J. J Virol 86 726-737 (2012)
  39. Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus. Schmid S, Sachs D, tenOever BR. J Biol Chem 289 299-311 (2014)
  40. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L. Nakanishi M, Goto Y, Kitade Y. Proteins 60 131-138 (2005)
  41. Interferon regulatory factor 3-CL, an isoform of IRF3, antagonizes activity of IRF3. Li C, Ma L, Chen X. Cell Mol Immunol 8 67-74 (2011)
  42. Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. Hong S, Kim HY, Kim J, Ha HT, Kim YM, Bae E, Kim TH, Lee KC, Kim SJ. J Biol Chem 288 3560-3570 (2013)
  43. Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity. Lee W, Lee SH, Kim M, Moon JS, Kim GW, Jung HG, Kim IH, Oh JE, Jung HE, Lee HK, Ku KB, Ahn DG, Kim SJ, Kim KS, Oh JW. Nat Commun 9 1606 (2018)
  44. A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3. Robitaille AC, Mariani MK, Fortin A, Grandvaux N. J Vis Exp e53723 (2016)
  45. Differential induction of gene promoter constructs by constitutively active human TLRs. Hasan UA, Dollet S, Vlach J. Biochem Biophys Res Commun 321 124-131 (2004)
  46. NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3. Wuerth JD, Habjan M, Wulle J, Superti-Furga G, Pichlmair A, Weber F. J Virol 92 e01202-18 (2018)
  47. Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain. Remesh SG, Santosh V, Escalante CR. J Biol Chem 290 27779-27790 (2015)
  48. TLR4-mediated blunting of inflammatory responses to eccentric exercise in young women. Fernandez-Gonzalo R, De Paz JA, Rodriguez-Miguelez P, Cuevas MJ, González-Gallego J. Mediators Inflamm 2014 479395 (2014)
  49. Comment Another detour on the Toll road to the interferon antiviral response. Hiscott J. Nat Struct Mol Biol 11 1028-1030 (2004)
  50. Interferon regulatory factor 6 (IRF6) is expressed in the ovine uterus and functions as a transcriptional activator. Fleming JA, Song G, Choi Y, Spencer TE, Bazer FW. Mol Cell Endocrinol 299 252-260 (2009)
  51. Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3. Yamamoto K, Yamamoto S, Ogasawara N, Takano K, Shiraishi T, Sato T, Miyata R, Kakuki T, Kamekura R, Kojima T, Tsutsumi H, Himi T, Yokota SI. Pharmacol Res 111 804-814 (2016)
  52. Deactylation by SIRT1 enables liquid-liquid phase separation of IRF3/IRF7 in innate antiviral immunity. Qin Z, Fang X, Sun W, Ma Z, Dai T, Wang S, Zong Z, Huang H, Ru H, Lu H, Yang B, Lin S, Zhou F, Zhang L. Nat Immunol 23 1193-1207 (2022)
  53. Mechanism of endogenous regulation of the type I interferon response by suppressor of IκB kinase epsilon (SIKE), a novel substrate of TANK-binding kinase 1 (TBK1). Marion JD, Roberts CF, Call RJ, Forbes JL, Nelson KT, Bell JE, Bell JK. J Biol Chem 288 18612-18623 (2013)
  54. Pestivirus Npro Directly Interacts with Interferon Regulatory Factor 3 Monomer and Dimer. Gottipati K, Holthauzen LM, Ruggli N, Choi KH. J Virol 90 7740-7747 (2016)
  55. The Structural Basis of IRF-3 Activation upon Phosphorylation. Jing T, Zhao B, Xu P, Gao X, Chi L, Han H, Sankaran B, Li P. J Immunol 205 1886-1896 (2020)
  56. Anti-pyroptotic function of TGF-β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells. Tamura Y, Morikawa M, Tanabe R, Miyazono K, Koinuma D. Mol Oncol 15 1289-1307 (2021)
  57. Comment IRF-3 releases its inhibitions. Hiscott J, Lin R. Structure 13 1235-1236 (2005)
  58. IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages. Moore TC, Al-Salleeh FM, Brown DM, Petro TM. Virology 418 40-48 (2011)
  59. A novel missense mutation in Van der Woude syndrome: usefulness of fingernail DNA for genetic analysis. Matsuzawa N, Shimozato K, Natsume N, Niikawa N, Yoshiura K. J Dent Res 85 1143-1146 (2006)
  60. Inactivating Mutation in IRF8 Promotes Osteoclast Transcriptional Programs and Increases Susceptibility to Tooth Root Resorption. Thumbigere-Math V, Foster BL, Bachu M, Yoshii H, Brooks SR, Coulter A, Chavez MB, Togi S, Neely AL, Deng Z, Mansky KC, Ozato K, Somerman MJ. J Bone Miner Res 34 1155-1168 (2019)
  61. Interferon regulatory factor 10 (IRF10): Cloning in orange spotted grouper, Epinephelus coioides, and evolutionary analysis in vertebrates. Huang B, Jia QQ, Liang Y, Huang WS, Nie P. Fish Shellfish Immunol 46 669-677 (2015)
  62. Priming Phosphorylation of TANK-Binding Kinase 1 by IκB Kinase β Is Essential in Toll-Like Receptor 3/4 Signaling. Abe H, Satoh J, Shirasaka Y, Kogure A, Kato H, Ito S, Fujita T. Mol Cell Biol 40 e00509-19 (2020)
  63. Modulation of innate immune response to viruses including SARS-CoV-2 by progesterone. Su S, Hua D, Li JP, Zhang XN, Bai L, Cao LB, Guo Y, Zhang M, Dong JZ, Liang XW, Lan K, Hu MM, Shu HB. Signal Transduct Target Ther 7 137 (2022)
  64. Transcription factor regulation and cytokine expression following in vitro infection of primary chicken cell culture with low pathogenic avian influenza virus. Jiang H, Yu K, Kapczynski DR. Virol J 10 342 (2013)
  65. Comment The nuts and bolts of IRF structure. Moustakas A, Heldin CH. Nat Struct Biol 10 874-876 (2003)
  66. Resemble and Inhibit: when RLR meets TGF-β. Zhu S, Li HB, Flavell RA. Mol Cell 56 719-720 (2014)
  67. Suppression of NF-kappaB and IRF-1-induced transcription of the murine IL-12 p40 by transforming growth factor-beta Smad pathway in macrophages. Ogawa K, Funaba M, Tsujimoto M. Mol Cell Biochem 308 9-15 (2008)
  68. Individual interferon regulatory factor-3 thiol residues are not critical for its activation following virus infection. Zucchini N, Williams V, Grandvaux N. J Interferon Cytokine Res 32 393-400 (2012)
  69. PolyI:C attenuates transforming growth factor-β signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer. Tamura Y, Tsutsumi S, Miyazono K, Koinuma D. Cancer Sci 113 940-949 (2022)
  70. Serine cluster phosphorylation liberates the C-terminal helix of IFN regulatory factor 7 to bind histone acetyltransferase p300. Lee KJ, Ye JS, Choe H, Nam YR, Kim N, Lee U, Joo CH. J Immunol 193 4137-4148 (2014)
  71. TOB1 attenuates IRF3-directed antiviral responses by recruiting HDAC8 to specifically suppress IFN-β expression. Yu Z, Wang L, Zhao J, Song H, Zhao C, Zhao W, Jia M. Commun Biol 5 943 (2022)
  72. Avian Metapneumovirus Subgroup C Phosphoprotein Suppresses Type I Interferon Production by Blocking Interferon Regulatory Factor 3 Nuclear Translocation. Hou L, Shi Y, Guo J, Sun T, Wang D, Yang X, Liu C, Cui Y, Zhu N, Tong X, Pan Y, Feng X, Zhou J, Liu J. Microbiol Spectr 11 e0341322 (2023)
  73. A Comprehensive Analysis of Interferon Regulatory Factor Expression: Correlation with Immune Cell Infiltration and Patient Prognosis in Endometrial Carcinoma. Lu X, Li R, Ying Y, Zhang W. Biomed Res Int 2022 7948898 (2022)
  74. African Swine Fever Virus Host-Pathogen Interactions. Netherton CL, Shimmon GL, Hui JYK, Connell S, Reis AL. Subcell Biochem 106 283-331 (2023)
  75. [On the occasion of retirement from Graduate School of Pharmaceutical Sciences, Hokkaido University]. Inagaki F. Yakugaku Zasshi 130 1251-1262 (2010)


Quick links